Health Policy
As GLP-1 Shortages Ease, Patient Safety Concerns Shift to Unsafe Copies
Unsafe compounded GLP-1 drugs remain a public health concern even as the FDA says shortages of major GLP-1 medications have eased. Federal official...
- Subash Kafle
Healthcare Leaders Spotlight Vaccine Equity and Adult Immunization Strategies at 2026 National Summit
Healthcare leaders from across the country gathered in Atlanta earlier this month for the 2026 National Adult and Influenza Immunization Summit, wh...
- Jessica Wilson
New Federal Data Standards Could Change How Communities of Color Are Counted in Health Care
Quick Answer: What is SPD 15?
SPD 15, or Statistical Policy Directive No. 15, is a federal standard created by the Office of Management and Budget ...
- Victor Mejia
PCOS Has a New Name… and It’s About Time
For years, I thought my body was fighting against me. My periods were irregular and sometimes disappeared for months at a time. I struggled with pa...
- Jessica Wilson
PCOS to PMOS: Why the 2026 Name Change Matters for Women’s Health
For millions of women living with what has long been known as polycystic ovary syndrome, the condition’s name has often felt incomplete, misleading...
Massachusetts Faces Backlash Over Proposed Cuts to Obesity Treatment Coverage
GLP-1 weight loss drug coverage is at the center of a growing healthcare debate in Massachusetts, where state leaders are considering cuts to cover...
- Subash Kafle
Trending Topics
Features
- Drive Toolkit
Download and distribute powerful vaccination QI resources for your community.
- Health Champions
Sign up now to support health equity and sustainable health outcomes in your community.
- Cancer Early Detection
MCED tests use a simple blood draw to screen for many kinds of cancer at once.
- PR
FYHN is a bridge connecting health information providers to BIPOC communities in a trusted environment.
- Medicare
Discover an honest look at our Medicare system.
- Alliance for Representative Clinical Trials
ARC was launched to create a network of community clinicians to diversify and bring clinical trials to communities of color and other communities that have been underrepresented.
- Reducing Patient Risk
The single most important purpose of our healthcare system is to reduce patient risk for an acute event.
